These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

661 related articles for article (PubMed ID: 25955318)

  • 1. Involvement of enhancer of zeste homolog 2 in cisplatin-resistance in ovarian cancer cells by interacting with several genes.
    Wang H; Yu Y; Chen C; Wang Q; Huang T; Hong F; Zhu L
    Mol Med Rep; 2015 Aug; 12(2):2503-10. PubMed ID: 25955318
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Gene expression profiling via bioinformatics analysis reveals biomarkers in laryngeal squamous cell carcinoma.
    Guan GF; Zheng Y; Wen LJ; Zhang DJ; Yu DJ; Lu YQ; Zhao Y; Zhang H
    Mol Med Rep; 2015 Aug; 12(2):2457-64. PubMed ID: 25936657
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Bioinformatics analysis of mRNA and miRNA microarray to identify the key miRNA-mRNA pairs in cisplatin-resistant ovarian cancer.
    Xue B; Li S; Jin X; Liu L
    BMC Cancer; 2021 Apr; 21(1):452. PubMed ID: 33892654
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Gene expression profiling of epithelial ovarian cancer reveals key genes and pathways associated with chemotherapy resistance.
    Zhang M; Luo SC
    Genet Mol Res; 2016 Jan; 15(1):. PubMed ID: 26909918
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Identification of the interaction network of hub genes for melanoma treated with vemurafenib based on microarray data.
    Quan L; Wang Y; Liang J; Shi J; Zhang Y; Tao K
    Tumori; 2015; 101(4):368-74. PubMed ID: 25983087
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Cross‑validation of genes potentially associated with neoadjuvant chemotherapy and platinum‑based chemoresistance in epithelial ovarian carcinoma.
    Zhang K; Wang W; Chen L; Liu Y; Hu J; Guo F; Tian W; Wang Y; Xue F
    Oncol Rep; 2020 Sep; 44(3):909-926. PubMed ID: 32705213
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Identification of candidate biomarkers and pathways associated with SCLC by bioinformatics analysis.
    Wen P; Chidanguro T; Shi Z; Gu H; Wang N; Wang T; Li Y; Gao J
    Mol Med Rep; 2018 Aug; 18(2):1538-1550. PubMed ID: 29845250
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Screening the molecular targets of ovarian cancer based on bioinformatics analysis.
    Du L; Qian X; Dai C; Wang L; Huang D; Wang S; Shen X
    Tumori; 2015; 101(4):384-9. PubMed ID: 25953442
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Topological network analysis of differentially expressed genes in cancer cells with acquired gefitinib resistance.
    Lee YS; Hwang SG; Kim JK; Park TH; Kim YR; Myeong HS; Kwon K; Jang CS; Noh YH; Kim SY
    Cancer Genomics Proteomics; 2015; 12(3):153-66. PubMed ID: 25977174
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Integrated bioinformatics analysis for the screening of hub genes and therapeutic drugs in ovarian cancer.
    Yang D; He Y; Wu B; Deng Y; Wang N; Li M; Liu Y
    J Ovarian Res; 2020 Jan; 13(1):10. PubMed ID: 31987036
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Analysis of the protein-protein interaction networks of differentially expressed genes in pulmonary embolism.
    Wang H; Wang C; Zhang L; Lu Y; Duan Q; Gong Z; Liang A; Song H; Wang L
    Mol Med Rep; 2015 Apr; 11(4):2527-33. PubMed ID: 25434468
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Co-expression network analysis of differentially expressed genes associated with metastasis in prolactin pituitary tumors.
    Zhang W; Zang Z; Song Y; Yang H; Yin Q
    Mol Med Rep; 2014 Jul; 10(1):113-8. PubMed ID: 24736764
    [TBL] [Abstract][Full Text] [Related]  

  • 13. A comprehensive analysis of candidate genes and pathways in pancreatic cancer.
    Liu J; Li J; Li H; Li A; Liu B; Han L
    Tumour Biol; 2015 Mar; 36(3):1849-57. PubMed ID: 25409614
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Prognostic values and prospective pathway signaling of MicroRNA-182 in ovarian cancer: a study based on gene expression omnibus (GEO) and bioinformatics analysis.
    Li Y; Li L
    J Ovarian Res; 2019 Nov; 12(1):106. PubMed ID: 31703725
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Screening candidate genes associated with bladder cancer using DNA microarray.
    Xu A; Wang C; Sun S
    Mol Med Rep; 2014 Dec; 10(6):3087-91. PubMed ID: 25323786
    [TBL] [Abstract][Full Text] [Related]  

  • 16. High-efficient Screening Method for Identification of Key Genes in Breast Cancer Through Microarray and Bioinformatics.
    Liu Z; Liang G; Tan L; Su AN; Jiang W; Gong C
    Anticancer Res; 2017 Aug; 37(8):4329-4335. PubMed ID: 28739725
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Identification of human prolactinoma related genes by DNA microarray.
    Zhao L; Lin M; Wang S
    J Cancer Res Ther; 2014; 10(3):544-8. PubMed ID: 25313736
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Bioinformatics analyses of significant genes, related pathways and candidate prognostic biomarkers in glioblastoma.
    Zhou L; Tang H; Wang F; Chen L; Ou S; Wu T; Xu J; Guo K
    Mol Med Rep; 2018 Nov; 18(5):4185-4196. PubMed ID: 30132538
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Cross-platform meta-analysis of multiple gene expression profiles identifies novel expression signatures in acquired anthracycline-resistant breast cancer.
    Lee YS; Ryu SW; Bae SJ; Park TH; Kwon K; Noh YH; Kim SY
    Oncol Rep; 2015 Apr; 33(4):1985-93. PubMed ID: 25695524
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Regulation of gene expression in rats with spinal cord injury based on microarray data.
    Chen G; Fang X; Yu M
    Mol Med Rep; 2015 Aug; 12(2):2465-72. PubMed ID: 25936407
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 34.